Showing results (561-570 of 596) with videos related to

Sort By:
Pageof 60
Thrombosis and Haemostasis|June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II studyC Leissinger, C D Josephson, S Granger, et al.
Pediatric Blood & Cancer|January 8, 2026
Hospital-Based Careers in Pediatric Hematology-Oncology: The State of the Field and Future NeedsAmbika Sohal, Jason L Freedman, Steven Aller, et al.
Haematologica|April 16, 2013
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionClaudia R Morris, Hae-Young Kim, John Wood, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 2019
Use of an expert panel to identify domains and indicators of delirium severityDena Schulman-Green, Eva M Schmitt, Tamara G Fong, et al.
Neuroimage. Clinical|December 20, 2025
Disrupted thalamocortical functional connectivity and canonical resting-state network integration in posttraumatic stress disorderNick Steele, Ahmed Hussain, Delin Sun, et al.
European Journal of Haematology|November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective studyJohn Porter, Renzo Galanello, Giuseppe Saglio, et al.
American Journal of Hematology|April 5, 2019
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomesRachael F Grace, Kristin A Shimano, Rukhmi Bhat, et al.
American Journal of Hematology|April 17, 2018
Physician decision making in selection of second-line treatments in immune thrombocytopenia in childrenRachael F Grace, Jenny M Despotovic, Carolyn M Bennett, et al.
Pageof 60